Stock.Research on 22 Dec 2000 00:48:22 -0000

[Date Prev] [Date Next] [Thread Prev] [Thread Next] [Date Index] [Thread Index]

[Nettime-bold] Stock Alert!!! ADV

You have been invited to receive our FREE email stock alert, focusing on undiscovered emerging growth companies. To unsubscribe, click here:

(OTC BB: SRGL) Recent Price: $2.88 with a 52 week high of $33.00
SurgiLight, Inc. operates various Laser Eye Centers worldwide and Mobile Cosmetic Centers in the United States. The Company also develops and conducts research for lasers in the ultraviolet and infrared spectra for applications in vision correction and microsurgery.

Laser Eye Center Profits Are Exploding!
Can you see the future!!!
Surgilight Inc. (OTC BB: SRGL) is a world leader in the development of new infrared (IR) laser technologies for both ophthalmology and dermatology. The Company has three patents pending for IR laser technologies that represent the generation lasers for both LASIK and presbyopia correction.
Surgilight Inc. was incorporated to acquire the technologies and laser centers associated with lasers for applications in ophthalmology, dermatology, industrial and military. The Company believes that its products represent substantial improvement in safety, precision, efficacy, time and cost effectiveness over currently available laser and non-laser devices. The Company currently has two divisions, Laser Technology and Laser Eye Centers. In the Laser Technology division, the Company develops and conducts research for lasers in the UV and infrared spectra for applications including vision correction and microsurgery. The Company also conducts clinical trials for various new applications including laser skin treatment and the patent pending device for laser presbyopia reversal. The Company currently operates 18 Laser Eye Centers internationally and one Eye Center and two Cosmetic Mobile Laser Center in Florida.

This release contains forward looking statements that are subject to risks and uncertainties, included but not limited to, certain delays beyond the company's control with respect to future business events; acceptance of the new technology; regulatory approvals; dependence on executive and operating personnel; sufficient financing for the Company to perform its contract obligations; ability to fulfill the Company's licensing requirements and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission.

The sender of this email received 2,250 shares of 144 restricted stock for services rendered over a three-month period.

Nettime-bold mailing list